市場調查報告書
商品編碼
956262

全球癌症生物標誌物市場規模調查:通過分析技術,生物分子,癌症類型,應用和地區進行的預測:2020-2027

Global Cancer Biomarkers Market Size study, by Profiling Technology, by Biomolecule, by Cancer Type, by Application and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2019年全球癌症生物標誌物市場約為109億美元。預計該市場在2020-2027年的預測期內將以超過11.8%的健康增長率增長。

根據世界衛生組織(WHO)的數據,癌症是世界上第二大死亡原因,佔2018年發達國家和發展中國家死亡的近70%。癌症生物標誌物是可追溯的分子或物質,指示人體中癌細胞的存在。生物標誌物可能顯示人體對腫瘤覆蓋的分子/物質或癌細胞的獨特反應。通過使用單獨的診斷技術測試幾種癌症生物標記物來預防和診斷癌症是實現快速治療結果的重要方法。蛋白質組學,遺傳學,糖鏈生物學和表觀遺傳學是可以廣泛用於癌症診斷,流行病學和預後的關鍵生物標誌物。癌症患者數量的增加,患者對癌症治療的意識的增強以及癌症生物標記物開發中投資和政府資金的增加,將是在預測期內可以大大增長市場的因素。

國際癌症研究機構(IARC)的數據顯示,2018年全球新增癌症病例數約為1810萬,癌症死亡人數為960萬。此外,到2040年,全球癌症患病率預計將增加到2750萬,新病例和1630萬癌症死亡。預計這將增加全球對癌症生物標誌物的需求。然而,在2020-2027年預測期內,疫苗開發的高昂成本以及政府監管和報銷政策不足,阻礙了市場的增長。

本報告對全球癌症生物標誌物市場進行了調查,並通過概要分析技術,生物分子,癌症類型,應用,地區和進入市場的公司概況提供了該市場的概述以及趨勢。

目錄

第1章執行摘要

第2章全球癌症生物標誌物市場的定義和範圍

第3章全球癌症生物標誌物市場動態

  • 癌症生物標誌物市場的影響分析(2018-2027)

第4章全球癌症生物標誌物市場:行業分析

  • 波特的五力模型
  • PEST分析
  • 投資採用模型
  • 分析師的建議和結論

第5章通過分析技術進行的全球癌症生物標誌物市場

  • 市場概況
  • 分析技術另一個全球癌症生物標誌物市場,性能潛能分析
  • 通過分析技術進行的全球癌症生物標誌物市場估計和預測:2017-2027(10億美元)
  • 癌症生物標誌物市場,細分分析
    • Omics技術
    • 成像技術
    • 免疫學檢查
    • 細胞遺傳學測試

第6章生物分子在全球癌症生物標誌物市場

  • 市場概況
  • 全球生物分子生物標記物市場,性能潛力分析
  • 按生物分子分列的全球癌症生物標誌物市場的估計和預測:2017-2027年調查(10億美元)
  • 癌症生物標誌物市場,細分分析
    • 遺傳生物標記
    • 蛋白質生物標誌物
    • 糖鏈生物標誌物

第7章按癌症類型劃分的全球癌症生物標誌物市場

  • 市場概況
  • 按癌症類型,表現潛能分析的全球癌症生物標誌物市場
  • 按癌症類型分列的全球癌症生物標誌物市場估計和預測:2017-2027年調查(10億美元)
  • 癌症生物標誌物市場,細分分析
    • 乳腺癌
    • 肺癌
    • 大腸癌
    • 前列腺癌
    • 胃癌
    • 其他

第8章按應用分列的全球癌症生物標誌物市場

  • 市場概況
  • 按應用,性能潛能分析的全球癌症生物標誌物市場
  • 按應用分列的全球癌症生物標誌物市場的估計和預測:2017-2027年調查(10億美元)
  • 癌症生物標誌物市場,細分分析
    • 診斷
    • 藥物發現與開發
    • 預後
    • 風險評估
    • 其他

第9章全球癌症生物標誌物市場,區域分析

  • 區域市場概況
  • 北美
    • 美國
    • 加拿大
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區快照
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他

第10章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Bristol-Myers Squibb Company
    • Exact Sciences Corporation
    • F.Hoffmann-La Roche Ltd.
    • Merck KGaA
    • PerkinElmer, Inc.
    • Qiagen N.V.
    • Siemens AG
    • Thermo Fisher Scientific, Inc

第11章調查流程

目錄

Title:
Global Cancer Biomarkers Market Size study, by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics-based Tests), by Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others), by Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Regional Forecasts 2020-2027.

Global Cancer Biomarkers Market is valued at approximately at USD 10.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.8% over the forecast period 2020-2027. According to the World Health Organization (WHO), cancer is the second major cause of death around the world and is responsible for nearly 70% of deaths occurred in the developed and developing countries in 2018. A cancer biomarker is the traceable molecule or substance that demonstrates the existence of cancerous cells in the human body. A biomarker may be a molecule/substance covered by a tumor or a specific response of the human body to the existence of cancerous cells. The prevention & diagnosis of cancer by examining several cancer biomarkers through the use of distinct diagnostic techniques is a profound approach to attain rapid results for treatment. Proteomic, genetic, glycomic, and epigenetic are the major biomarkers that can be extensively used for cancer diagnosis, epidemiology and prognosis. An increase in the number of cancer patients, growing awareness among patients towards cancer therapy, and rising investment and government funding in the development of cancer biomarkers are the few factors responsible for the impressive growth of the market during the forecast period. According to the International Agency for Research on Cancer (IARC), there were approximately 18.1 million novel cases of cancer and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for Cancer Biomarkers, globally. However, the high development cost of vaccine and unregulated government regulations and reimbursement policies are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Cancer Biomarkers market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising usage of cancer biomarkers in drug discovery and development, along with the large presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:

Abbott Laboratories

Bio-Rad Laboratories, Inc.

Bristol-Myers Squibb Company

Exact Sciences Corporation

F.Hoffmann-La Roche Ltd.

Merck KGaA

PerkinElmer, Inc.

Qiagen N.V.

Siemens AG

Thermo Fisher Scientific, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Profiling Technology:

Omic Technologies

Imaging Technologies

Immunoassays

Cytogenetics-based Tests

By Biomolecule:

Genetic Biomarkers

Protein Biomarkers

Glyco-biomarkers

By Cancer Type:

Breast Cancer

Lung Cancer

Colorectal Cancer

Prostate Cancer

Stomach Cancer

Others

By Application:

Diagnostics

Drug Discovery and Development

Prognostics

Risk Assessment

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Cancer Biomarkers Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Cancer Biomarkers Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Cancer Biomarkers Market, by Profiling Technology, 2018-2027 (USD Billion)
    • 1.2.3. Cancer Biomarkers Market, by Biomolecule, 2018-2027 (USD Billion)
    • 1.2.4. Cancer Biomarkers Market, by Cancer Type, 2018-2027 (USD Billion)
    • 1.2.5. Cancer Biomarkers Market, by Application, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cancer Biomarkers Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Biomarkers Market Dynamics

  • 3.1. Cancer Biomarkers Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cancer Biomarkers Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Biomarkers Market, by Profiling Technology

  • 5.1. Market Snapshot
  • 5.2. Global Cancer Biomarkers Market by Profiling Technology, Performance - Potential Analysis
  • 5.3. Global Cancer Biomarkers Market Estimates & Forecasts by Profiling Technology 2017-2027 (USD Billion)
  • 5.4. Cancer Biomarkers Market, Sub Segment Analysis
    • 5.4.1. Omic Technologies
    • 5.4.2. Imaging Technologies
    • 5.4.3. Immunoassays
    • 5.4.4. Cytogenetics-based Tests

Chapter 6. Global Cancer Biomarkers Market, by Biomolecule

  • 6.1. Market Snapshot
  • 6.2. Global Cancer Biomarkers Market by Biomolecule, Performance - Potential Analysis
  • 6.3. Global Cancer Biomarkers Market Estimates & Forecasts by Biomolecule 2017-2027 (USD Billion)
  • 6.4. Cancer Biomarkers Market, Sub Segment Analysis
    • 6.4.1. Genetic Biomarkers
    • 6.4.2. Protein Biomarkers
    • 6.4.3. Glyco-biomarkers

Chapter 7. Global Cancer Biomarkers Market, by Cancer Type

  • 7.1. Market Snapshot
  • 7.2. Global Cancer Biomarkers Market by Cancer Type, Performance - Potential Analysis
  • 7.3. Global Cancer Biomarkers Market Estimates & Forecasts by Cancer Type 2017-2027 (USD Billion)
  • 7.4. Cancer Biomarkers Market, Sub Segment Analysis
    • 7.4.1. Breast Cancer
    • 7.4.2. Lung Cancer
    • 7.4.3. Colorectal Cancer
    • 7.4.4. Prostate Cancer
    • 7.4.5. Stomach Cancer
    • 7.4.6. Others

Chapter 8. Global Cancer Biomarkers Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Cancer Biomarkers Market by Application - Potential Analysis
  • 8.3. Global Cancer Biomarkers Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 8.4. Cancer Biomarkers Market, Sub Segment Analysis
    • 8.4.1. Diagnostics
    • 8.4.2. Drug Discovery and Development
    • 8.4.3. Prognostics
    • 8.4.4. Risk Assessment
    • 8.4.5. Others

Chapter 9. Global Cancer Biomarkers Market, Regional Analysis

  • 9.1. Cancer Biomarkers Market, Regional Market Snapshot
  • 9.2. North America Cancer Biomarkers Market
    • 9.2.1. U.S. Cancer Biomarkers Market
      • 9.2.1.1. Profiling Technology breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Biomolecule breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Cancer Type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. Application breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Cancer Biomarkers Market
  • 9.3. Europe Cancer Biomarkers Market Snapshot
    • 9.3.1. U.K. Cancer Biomarkers Market
    • 9.3.2. Germany Cancer Biomarkers Market
    • 9.3.3. France Cancer Biomarkers Market
    • 9.3.4. Spain Cancer Biomarkers Market
    • 9.3.5. Italy Cancer Biomarkers Market
    • 9.3.6. Rest of Europe Cancer Biomarkers Market
  • 9.4. Asia-Pacific Cancer Biomarkers Market Snapshot
    • 9.4.1. China Cancer Biomarkers Market
    • 9.4.2. India Cancer Biomarkers Market
    • 9.4.3. Japan Cancer Biomarkers Market
    • 9.4.4. Australia Cancer Biomarkers Market
    • 9.4.5. South Korea Cancer Biomarkers Market
    • 9.4.6. Rest of Asia Pacific Cancer Biomarkers Market
  • 9.5. Latin America Cancer Biomarkers Market Snapshot
    • 9.5.1. Brazil Cancer Biomarkers Market
    • 9.5.2. Mexico Cancer Biomarkers Market
  • 9.6. Rest of The World Cancer Biomarkers Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Bio-Rad Laboratories, Inc.
    • 10.2.3. Bristol-Myers Squibb Company
    • 10.2.4. Exact Sciences Corporation
    • 10.2.5. F.Hoffmann-La Roche Ltd.
    • 10.2.6. Merck KGaA
    • 10.2.7. PerkinElmer, Inc.
    • 10.2.8. Qiagen N.V.
    • 10.2.9. Siemens AG
    • 10.2.10. Thermo Fisher Scientific, Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF FIGURES

  • FIG 1. Global Cancer Biomarkers market, research methodology
  • FIG 2. Global Cancer Biomarkers market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cancer Biomarkers market, key trends 2019
  • FIG 5. Global Cancer Biomarkers market, growth prospects 2020-2027
  • FIG 6. Global Cancer Biomarkers market, porters 5 force model
  • FIG 7. Global Cancer Biomarkers market, pest analysis
  • FIG 8. Global Cancer Biomarkers market, value chain analysis
  • FIG 9. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Cancer Biomarkers market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Cancer Biomarkers market, regional snapshot 2017 & 2027
  • FIG 18. North America Cancer Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Cancer Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Cancer Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Cancer Biomarkers market 2017 & 2027 (USD Billion)
  • FIG 22. Global Cancer Biomarkers market, company market share analysis (2019)